Published April 15, 2011 | Version v1
Journal article

Akt2 and nucleophosmin/B23 function as an oncogenic unit in human lung cancer cells

  • 1. Center for Molecular Medicine, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon 440-746 (Korea, Republic of)
  • 2. Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon 440-746 (Korea, Republic of)
  • 3. Department of Anatomy, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon 440-746 (Korea, Republic of)
  • 4. Department of Biochemistry and Molecular Biology, University of Ulsan, College of Medicine, Seoul 138-736 (Korea, Republic of)

Description

The signaling network of protein kinase B(PKB)/Akt has been implicated in survival of lung cancer cells. However, understanding the relative contribution of the different isoform of Akt network is nontrival. Here, we report that Akt2 is highly expressed in human lung adenocarcinoma cell line A549 cells. Suppression of Akt2 expression in A549 cells results in notable inhibition of cell poliferation, soft agar growth, and invasion, accompanying by a decrease of nucleophosmin/B23 protein. Overexpression of Akt1 restores cancerous growth of A549 cells in B23-knockdown (KD) cells while Akt2 overexpression did not restore proliferating potential in cells with downregulated B23, thus suggesting Akt2 requires B23 to drive proliferation of lung cancer cell. Loss of functional Akt2 and B23 has similar defects on cell proliferation, apoptotic resistance and cell cycle regulation, while loss of Akt1 has less defects on cell proliferation, survial and cell cycle progression in A549 cells. Moreover, overexpression of B23 rescues the proliferative block induced as a consequence of loss of Akt2. Thus our data suggest that Akt2/B23 functions as an oncogenic unit to drive tumorigenesis of A549 lung cancer cells.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.yexcr.2010.12.013

Additional details

Identifiers

DOI
10.1016/j.yexcr.2010.12.013;
PII
S0014-4827(10)00571-9;

Publishing Information

Journal Title
Experimental Cell Research
Journal Volume
317
Journal Issue
7
Journal Page Range
p. 966-975
ISSN
0014-4827
CODEN
ECREAL

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
45033063
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
AGAR; CARCINOMAS; CELL CYCLE; CELL PROLIFERATION; INHIBITION; LUNGS; PROTEINS
Descriptors DEC
BODY; CARBOHYDRATES; COLLOIDS; DISEASES; DISPERSIONS; NEOPLASMS; ORGANIC COMPOUNDS; ORGANS; POLYSACCHARIDES; RESPIRATORY SYSTEM; SACCHARIDES

Optional Information

Copyright
Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.